Details

Last Funding Type

Series A

Last Funding Money Raised

$35M

Industries

Biotechnology,Health Care,Medical,Therapeutics

Founded date

Jan 1, 2016

Number Of Employee

1 - 10

Operating Status

Active

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer through the selective modulation of oncogene translation. The company is modulating oncogene translation to dramatically improve cancer patient outcomes. Their precision-based therapeutics target the “master switch” of cancer signaling pathways, selectively blocking oncogene protein production by modulating the Pre-Initiation Complex (PIC) that drives their mRNA translation. Its selective approach has the potential to simultaneously modulate multiple oncogenic drivers leading to a powerful new generation of cancer-treating therapeutics.

PIC Therapeutics was founded in 2016 and is headquartered in Natick, Massachusetts, United States.